SCHEMBL2312464

SCHEMBL2312464

O=C(O)Oc1cccc2[nH]ccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RHEB Q15382 4/20 0.49
KMT2A Q03164 3/20 0.48
PARP1 P09874 1/20 0.48
HSD17B10 Q99714 1/20 0.48
MCL1 Q07820 1/20 0.47
TRPA1 O75762 1/20 0.46
HTR1A P08908 4/20 0.44
DRD4 P21917 2/20 0.44
DRD3 P35462 2/20 0.44
DRD2 P14416 1/20 0.44
AHR P35869 1/20 0.44
SLC22A6 Q4U2R8 1/20 0.44
TUBB4A P04350 1/20 0.43
TUBB P07437 1/20 0.43
TUBA3C P0DPH7 1/20 0.43
TUBA1B P68363 1/20 0.43
TUBA4A P68366 1/20 0.43
TUBB4B P68371 1/20 0.43
TUBB3 Q13509 1/20 0.43
TUBB2A Q13885 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridine SCHEMBL9320487 0.91 PIK3CD (0.45) RHEBKMT2APARP1HSD17B10MCL1
SCHEMBL29511854 0.84 SLC22A6 (0.63) RHEBKMT2APARP1HSD17B10MCL1
SCHEMBL9871925 0.84 RHEB (0.51) RHEBKMT2APARP1HSD17B10MCL1
SCHEMBL594038 0.84 SLC22A6 (0.63) RHEBKMT2APARP1HSD17B10MCL1
SCHEMBL8995160 0.83 KMT2A (0.69) RHEBKMT2APARP1HSD17B10MCL1
SCHEMBL30514396 0.83 KMT2A (0.69) RHEBKMT2APARP1HSD17B10MCL1
SCHEMBL8801424 0.81 HTR1B (0.50) RHEBKMT2AHSD17B10TRPA1HTR1A
SCHEMBL7495860 0.80 BCHE (0.60) RHEBKMT2AHTR1ADRD4DRD3
SCHEMBL30248943 0.80 ELANE (0.49) RHEBKMT2APARP1HSD17B10MCL1
SCHEMBL8583050 0.80 SLC22A6 (0.46) RHEBKMT2APARP1HSD17B10MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1888579-B1 NOVEL FLUORENE DERIVATIVES, COMPOSITION CONTAINING SAID DERIVATIVES AND THE USE THEREOF AVENTIS PHARMA SA (FR) 2011-08-03 EP claimed
EP-1310510-B1 Topologically segregated, encoded solid phase libraries AVENTIS PHARMA INC (US) 2007-07-11 EP claimed
EP-0705279-B1 TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES SELECTIDE CORP (US) 2003-02-19 EP claimed
EP-0743574-B1 Migration imaging members XEROX CORP (US) 2000-12-27 EP claimed
EP-0743573-B1 Method for obtaining image contrast migration imaging members XEROX CORP (US) 2000-09-06 EP claimed
EP-0673782-B1 Recording sheets containing pyrrole, pyrrolidine, pyridine, piperidine, homopiperidine, quinoline, isoquinoline, quinuclidine, indole, and indazole compounds XEROX CORP (US) 2000-06-14 EP claimed
EP-1590324-B1 NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A sb 2 /sb MERCKLE GMBH (DE) 2009-03-11 EP disclosed
EP-1590324-A1 NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A sb 2 /sb MERCKLE GMBH (DE) 2005-11-02 EP disclosed
WO-2004069797-A1 NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A2 MERCKLE GMBH (DE) 2004-08-19 WO disclosed
EP-0640616-B1 17-Alkylcarbonate, 21-0-carbonic/carboxylic acid esters of corticosteroids, a method for their production and pharmaceutical compositions containing them HOECHST AG (DE) 2002-11-27 EP disclosed
EP-0646593-A1 Corticoid-17,21-dicarboxylic acid ester and corticosteroid-17-carboxylic acid ester-21-carbonic, process for their production and medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1995-04-05 EP disclosed
EP-0640616-A2 17-Alkylcarbonate, 21-0-carbonic/carboxylic acid esters of corticosteroids, a method for their production and pharmaceutical compositions containing them HOECHST AKTIENGESELLSCHAFT (DE) 1995-03-01 EP disclosed